![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Highlights from iwCLL 2019: MRD and novel therapies (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Varying efficacies of combination and monotherapies in CLL (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Predictors in the novel therapy era (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
The mechanism of ibrutinib in CLL treatment (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Update from the IWCLL 2017 (HMP Education) View |
![]() |
Dr. Michael Hallek - Novel Agents: How are drugs being used in the future (The Leukemia \u0026 Lymphoma Society of Canada) View |
![]() |
Additional Therapies for R/R CLL (OncLive) View |
![]() |
iwCLL 2013: Prof Michael Hallek Part 2 on the Role of Chemo-immunotherapy (Brian Koffman) View |
![]() |
Case 1: Prognostic Features and Chemoimmunotherapy Treatment Options (Targeted Oncology) View |
![]() |
Therapeutic Approaches for R/R CLL (OncLive) View |